Mendelian Disease genes on Chromosome 5 (from OMIM)
Band Name of Disorder (MIM # of disorder) Gene Symbols MIM# of Locus
5p15.33 Hartnup disorder (234500) HND, SLC6A19
5p15.31 Homocystinuria-megaloblastic anemia, cbl E type (236270) MTRR 602568
5p15.2 Craniometaphyseal dysplasia (123000) ANKH, HANK, ANK, 605145
CMDJ, CCAL2, CPPDD
5p15 Leigh syndrome (256000); Mitochondrial respiratory chain SDHA, SDH2, SDHF 600857
complexII deficiency (252011)
5p15-p14 Primary ciliary dyskinesia (242650); Kartagener syndrome (244400) DNAH5, HL1, PCD 603335
5p13.3 Alpha-methylacyl-CoA racemase deficiency AMACR 604489
5p13.3 Laron dwarfism (262500) GHR 600946
5p13.3 Oculocutaneous albinism, type IV (606574) MATP, AIM1 606202
5p13.3-p13.2 Brachydactyly, type A1 (112500) BDA1B
5p13.2 Severe combined immunodeficiency, T-cell negative, IL7R 146661
B-cell/natural killer cell-positive type, 600802
5p13.1 Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome (601559) LIFR, STWS, SWS, SJS2 151443
5p13.1 Ketoacidosis due to SCOT deficiency SCOT, OXCT 245050
5q11.2 Molybdenum cofactor deficiency, type B (252150) MOCS2, MPTS 603708
5q11.2 Complex I deficiency (252010); Leigh syndrome (256000) NDUFS4, AQDQ 602694
5q11.2 Polycystic ovary syndrome (184700) FST, FS 136470
Klippel-Feil syndrome (214300) KFS
5q11.2 Neonatal alloimmune thrombocytopenia ITGA2, CD49B, BR 192974
5q12.1 Cockayne syndrome 1, classical (216400) CKN1
5q13.2 3-Methylcrotonylglycinuria II MCCC2, MCCB 210210
5q13.1-5q13.2 Spinal muscular atrophy-1 (253300); SMA-2 (253550); SMN1, SMA1, SMA2, 600354
SMA-3 (253400) ;SMA-4 (271150) SMA3, SMA4
5q13.3 Sandhoff disease (268800) HEXB 606873
5q13.3 Klippel-Trenaunay syndrome (149000) VG5Q, HUS84971, 608464
FLJ10283
5q13-q14 Aortic aneurysm, familial thoracic 2 (607087) AAT2, FAA2
Wagner syndrome (143200) WGN1, ERVR
5q13-q22 Capillary malformations, hereditary (163000) CMAL
Fibromatosis, gingival (605544; 135300) GINGF2, GGF2, HGF2
5q14.1 Hermansky-Pudlak syndrome (608233) AP3B1, ADTB3A, HPS2 603401
5q14.1 Maroteaux-Lamy syndrome ARSB 253200
5q14.1 Dimethylglycine dehydrogenase deficiency (605850) DMGDH, DMGDHD 605849
5q14.3 Parkes Weber syndrome (608355); RASA1, GAP, CMAVM, 139150
Capillary malformation-arteriovenous malformation (608354) PKWS
5q14.3 Convulsions, familial febrile (604352); Usher syndrome, MASS1, VLGR1, FEB4 602851
typeIIC (605472) KIAA0686, USH2C
5q15 Obesity with impaired prohormone processing (600955) PCSK1, NEC1, PC1, PC3 162150
5q22.2 Colorectal cancer MCC 159350
5q22.2 Gardner syndrome; Adenomatous polyposis coli; Desmoid disease, APC, GS, FPC 175100
hereditary (135290); Turcot syndrome (276300)
5q23.1 D-bifunctional protein deficiency (261515) HSD17B4 601860
5q23.1 Cutis laxa, recessive, type I (219100) LOX 153455
5q23.2 Contractural arachnodactyly, congenital FBN2, CCA 121050
5q23.3 Carnitine deficiency, systemic primary (212140) SLC22A5, OCTN2, 603377
CDSP, SCD
5q23.3 Myelodysplastic syndrome; Myelogenous leukemia, acute FACL6, ACS2 604443
5q31 Inflammatory bowel disease-5 (266600) IBD5 606348
5q31 Marinesco-Sjogren syndrome MSS 248800
5q31 Paget disease of bone (602080) PDB4 606263
5q31.1 Corneal dystrophy (121900; 122200; 608470; 607541; TGFBI, CSD2, CDGG1, 601692
607541; 608471; 602082) CSD, BIGH3, CDG2
5q31.1 Leukemia, acute promyelocytic, NPM/RARA type NPM1 164040
5q31.1 Anderson disease (607689); Chylomicron retention disease (246700); SARA2, SAR1B, CMRD 607690
Chylomicron retention disease with Marinesco-Sjogren
syndrome (607692)
5q31.2 Muscular dystrophy, limb-girdle, type 1A (159000) TTID, MYOT 604103
5q31.2-q31.3 Epilepsy, pyridoxine-dependent (266100) EPD, PDE
5q31.3 Deafness, autosomal dominant (124900) DIAPH1, DFNA1, LFHL1 602121
5q31.3 Diphtheria, susceptibility to DTR, DTS, HBEGF, 126150
HEGFL
5q31.3 Leukemia, juvenile myelomonocytic (607785) GRAF 605370
5q31.3 Cortisol resistance NR3C1, GCR, GRL 138040
5q31-q33 Eosinophilia, familial EOS 131400
5q31-q33 Plasmodium falciparum parasitemia, intensity of PFBI 248310
5q31-q33 Schistosoma mansoni infection, susceptibility/resistance to SM1 181460
5q31-5q32 Myopathy, distal 2 (606070) MPD2
5q32 Pancreatitis, hereditary (167800); SPINK1, PSTI, PCTT, 167790
Tropical calcific pancreatitis (608189) TATI
5q32 Spinocerebellar ataxia 12 (604326) PPP2R2B 604325
5q32 Deafness, autosomal dominant 15 (602459) POU4F3, BRN3C 602460
5q32-q33.1 Diastrophic dysplasia (222600); Atelosteogenesis II (256050); SLC26A2, DTD, DTDST, 606718
Achondrogenesis Ib (600972); Epiphyseal dysplasia, D5S1708, EDM4
multiple (226900)
5q33.1 Myeloproliferative disorder with eosinophilia (131440) PDGFRB, PDGFR 173410
5q33.1 Retinitis pigmentosa, autosomal recessive PDE6A, PDEA 180071
5q33.1 GM2-gangliosidosis, AB variant GM2A 272750
5q33.1 Startle disease/hyperekplexia, autosomal dominant (149400) GLRA1, STHE 138491
5q33.1 Charcot-Marie-Tooth disease, type 4C (601596) KIAA1985 608206
5q33.1 Netherton syndrome (256500) SPINK5, LEKTI 605010
5q33.1 Treacher Collins-Franceschetti syndrome-1 (TREACLE; 606847) TCOF1, MFD1
5q33.1 Myeloid malignancy, predisposition to CSF1R, FMS 164770
5q33.3 BCG and salmonella infection, disseminated (209950) IL12B, NKSF2 161561
5q33.3 Muscular dystrophy, limb-girdle, type 2F (601287); SGCD, SGD, LGMD2F, 601411
Cardiomyopathy, dilated, 1L (606685) CMD1L
5q34 Epilepsy, juvenile myoclonic (606904) GABRA1 137160
5q35.3 Ehlers-Danlos syndrome, type VIIC (225410) ADAMTS2, NPI 604539
5q35.3 Factor XII deficiency F12, HAF 234000
5q34 Epilepsy, generalized, with febrile seizures plus (604233); GABRG2, GEFSP3, 137164
Epilepsy, childhood absence (607681); Myoclonic epilepsy, CAE2, ECA2
severe, of infancy (607208)
5q35.3 Pituitary hormone deficiency, combined PROP1 601538
5q35 Arthrogryposis multiplex congenita, neurogenic AMCN, AMCN1 208100
5q35.1 Atrial septal defect with atrioventricular conduction defects NKX2E, CSX 600584
(108900); Tetrology of Fallot (187500)
5q35.2 Craniosynostosis, type 2 (604757); Parietal foramina 1 (168500) MSX2, CRS2, HOX8 123101
5q35.2-q35.3 Sotos syndrome (117550); Leukemia, acute myeloid (601626); NSD1, ARA267, STO 606681
Weaver syndrome (277590)
5q35.2 Cancer progression/metastasis FGFR4 134935
5q35.3 Ehlers-Danlos syndrome, progeroid form (130070) B4GALT7, XGALT1, XGPT1 604327
5q35.3 Lymphedema, hereditary I (153100); Hemangioma, FLT4, VEGFR3, PCL 136352
capillaryinfantile, somatic (602089)